Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,078
Closed -$151K 378
2025
Q4
$151K Buy
+6,078
New +$153K 0.04% 136
2025
Q2
Sell
-9,227
Closed -$234K 118
2025
Q1
$234K Sell
9,227
-861
-9% -$22.5K 0.07% 109
2024
Q4
$268K Sell
10,088
-990
-9% -$26.9K 0.08% 109
2024
Q3
$321K Sell
11,078
-1,167
-10% -$34K 0.09% 104
2024
Q2
$343K Buy
12,245
+717
+6% +$19.7K 0.11% 99
2024
Q1
$320K Sell
11,528
-2,693
-19% -$74.7K 0.11% 104
2023
Q4
$409K Sell
14,221
-11,327
-44% -$342K 0.14% 100
2023
Q3
$847K Sell
25,548
-1,429
-5% -$50.5K 0.32% 60
2023
Q2
$990K Sell
26,977
-2,270
-8% -$88.4K 0.39% 46
2023
Q1
$1.19M Sell
29,247
-343
-1% -$14.8K 0.5% 34
2022
Q4
$1.52M Sell
29,590
-536
-2% -$25.7K 0.63% 29
2022
Q3
$1.32M Sell
30,126
-44
-0.1% -$2.14K 0.59% 26
2022
Q2
$1.58M Sell
30,170
-462
-2% -$23.5K 0.69% 25
2022
Q1
$1.52M Sell
30,632
-1,367
-4% -$70.9K 0.64% 27
2021
Q4
$1.89M Sell
31,999
-1,150
-3% -$57K 0.75% 26
2021
Q3
$1.43M Sell
33,149
-305
-0.9% -$13.5K 0.6% 31
2021
Q2
$1.31M Buy
33,454
+1,176
+4% +$45.7K 0.55% 37
2021
Q1
$1.17M Buy
+32,278
New +$1.15M 0.52% 38

Other funds holding PFE

Navalign LLC's PFE Position: Q1 2026 in Review

Navalign LLC sold out of Pfizer (PFE) in Q1 2026, closing a stake of 6,078 shares — an estimated $151K sold.

Navalign LLC first reported a position in PFE in Q1 2021 and held it in 18 quarters. The position peaked at $1.89M in Q4 2021. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Navalign LLC reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Navalign LLC sold 6,078 Pfizer shares in Q1 2026, an estimated $151K.
  • Navalign LLC first reported a position in Pfizer in Q1 2021 and held it in 18 quarters.
  • Navalign LLC's Pfizer position peaked at $1.89M in Q4 2021.
  • 2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Navalign LLC's 13F filing for Q1 2026, filed 29 Apr 2026.